- Corporate Officers - G
- Garay Arpa
Insider Trading History of Garay Arpa
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Garay Arpa since 2022.
This trader's CIK number is 1916360.
At the time of last reporting, Garay Arpa was the Chief Commercial Officer of Moderna, Inc.. (stock ticker symbol MRNA).
Also see all insider trading activities at Moderna, Inc..
Note that in the past
Garay Arpa also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Moderna, Inc. (MRNA) by Garay Arpa
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | MRNA | 0 | $0 | 3,428 | $394,373 | 6,843 | $0 |
Yearly summary of insider trading at Merck & Co., Inc. (MRK) by Garay Arpa
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | MRK | 0 | $0 | 0 | $0 | 2,412 | $212,311 |
Insider trading activities at 2 companies by Garay Arpa:
1. Moderna, Inc. (MRNA)
2. Merck & Co., Inc. (MRK)
Table 1. Insider trading of Moderna, Inc. (MRNA) by Garay Arpa
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-12-06 | MRNA | Sale | 564 | 78.34 | 44,182 |
| 2023-12-05 | MRNA | Option Ex | 1,141 | .00 | 0 |
| 2023-09-06 | MRNA | Sale | 574 | 108.40 | 62,219 |
| 2023-09-05 | MRNA | Option Ex | 1,140 | .00 | 0 |
| 2023-06-05 | MRNA | Option Ex | 4,562 | .00 | 0 |
| 2023-06-06 | MRNA | Sale | 2,290 | 125.75 | 287,972 |
Table 2. Insider trading of Merck & Co., Inc. (MRK) by Garay Arpa
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-05-03 | MRK | Option Ex | 773 | 87.65 | 67,753 |
| 2022-05-03 | MRK | Option Ex | 773 | 87.65 | 67,753 |
| 2022-05-01 | MRK | Option Ex | 866 | 88.69 | 76,805 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Garay Arpa
(Chief Commercial Officer of Moderna, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.